Brian Cleaver

970 total citations
19 papers, 663 citations indexed

About

Brian Cleaver is a scholar working on Molecular Biology, Agronomy and Crop Science and Genetics. According to data from OpenAlex, Brian Cleaver has authored 19 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Agronomy and Crop Science and 5 papers in Genetics. Recurrent topics in Brian Cleaver's work include Reproductive Physiology in Livestock (7 papers), Virus-based gene therapy research (5 papers) and Veterinary Equine Medical Research (5 papers). Brian Cleaver is often cited by papers focused on Reproductive Physiology in Livestock (7 papers), Virus-based gene therapy research (5 papers) and Veterinary Equine Medical Research (5 papers). Brian Cleaver collaborates with scholars based in United States, Canada and Germany. Brian Cleaver's co-authors include Nathalie Clément, Barry J. Byrne, Thomas J. Conlon, Barbara K. Smith, David D. Fuller, Saleem Islam, Shelley Collins, Lee Ann Lawson, Cathryn Mah and Manuela Corti and has published in prestigious journals such as Human Molecular Genetics, Biology of Reproduction and Reproduction.

In The Last Decade

Brian Cleaver

17 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Cleaver United States 13 371 279 193 90 72 19 663
Shunichi Suzuki Japan 17 378 1.0× 251 0.9× 84 0.4× 11 0.1× 42 0.6× 62 841
Hironori Okada Japan 14 342 0.9× 171 0.6× 33 0.2× 13 0.1× 23 0.3× 36 527
Peter L Whitfeld Australia 10 219 0.6× 82 0.3× 68 0.4× 30 0.3× 43 0.6× 10 709
Ilona Zvetkova United Kingdom 10 961 2.6× 478 1.7× 102 0.5× 26 0.3× 40 0.6× 13 1.3k
Lisa Clepper United States 12 966 2.6× 187 0.7× 88 0.5× 14 0.2× 57 0.8× 18 1.3k
Pádraig Hart United States 9 396 1.1× 193 0.7× 57 0.3× 7 0.1× 69 1.0× 14 755
Peter S. Mountford Australia 10 784 2.1× 264 0.9× 50 0.3× 7 0.1× 20 0.3× 13 945
Oskar Lechner Austria 14 249 0.7× 139 0.5× 33 0.2× 60 0.7× 16 0.2× 20 898
J. Teyssier France 12 167 0.5× 102 0.4× 36 0.2× 45 0.5× 23 0.3× 22 516
Maria Strazzullo Italy 19 596 1.6× 241 0.9× 27 0.1× 13 0.1× 49 0.7× 42 905

Countries citing papers authored by Brian Cleaver

Since Specialization
Citations

This map shows the geographic impact of Brian Cleaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Cleaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Cleaver more than expected).

Fields of papers citing papers by Brian Cleaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Cleaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Cleaver. The network helps show where Brian Cleaver may publish in the future.

Co-authorship network of co-authors of Brian Cleaver

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Cleaver. A scholar is included among the top collaborators of Brian Cleaver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Cleaver. Brian Cleaver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Corti, Manuela, Barry J. Byrne, Dominic J. Gessler, et al.. (2023). Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation. Molecular Therapy — Methods & Clinical Development. 30. 303–314. 15 indexed citations
2.
Byrne, Barry J., David D. Fuller, Barbara K. Smith, et al.. (2019). Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy. Annals of Translational Medicine. 7(13). 290–290. 38 indexed citations
3.
4.
Corti, Manuela, Brian Cleaver, Nathalie Clément, et al.. (2018). Enabling redosing of AAV by immune management in Pompe disease: Preclinical to clinical studies. Molecular Genetics and Metabolism. 123(2). S34–S34. 1 indexed citations
5.
Potter, Mark, et al.. (2016). A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform. Molecular Therapy — Methods & Clinical Development. 3. 16031–16031. 33 indexed citations
6.
Corti, Manuela, Brian Cleaver, Nathalie Clément, et al.. (2015). Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning. PubMed. 26(3). 185–193. 79 indexed citations
7.
Byrne, Barry J., Barbara K. Smith, Cathryn Mah, et al.. (2014). Phase I/II Trial of Diaphragm Delivery of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase (rAAV1-CMV- GAA ) Gene Vector in Patients with Pompe Disease. PubMed. 25(3). 134–163. 34 indexed citations
8.
Potter, Mark, Mario Mietzsch, Regine Heilbronn, et al.. (2014). A simplified purification protocol for recombinant adeno-associated virus vectors. Molecular Therapy — Methods & Clinical Development. 1. 14034–14034. 58 indexed citations
9.
Conlon, Thomas J., Wen‐Tao Deng, Kirsten Erger, et al.. (2013). Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of MERTK Associated Retinitis Pigmentosa. PubMed. 24(1). 23–28. 79 indexed citations
10.
Smith, Barbara K., Shelley Collins, Thomas J. Conlon, et al.. (2013). Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes. Human Gene Therapy. 24(6). 630–640. 127 indexed citations
11.
Byrne, Barry J., Darin J. Falk, Christina A. Pacak, et al.. (2011). Pompe disease gene therapy. Human Molecular Genetics. 20(R1). R61–R68. 72 indexed citations
12.
Cleaver, Brian, et al.. (2001). Effects of ovarian input on GnRH and LH secretion immediately postovulation in pony mares. Theriogenology. 55(5). 1095–1106. 4 indexed citations
13.
Sharp, Daniel C., Michael W. Wolfe, Brian Cleaver, & John H. Nilson. (2001). Effects of estradiol-17ß administration on steady-state messenger ribonucleic acid (MRNA) encoding equine α and LH/CGß subunits in pituitaries of ovariectomized pony mares. Theriogenology. 55(5). 1083–1093. 13 indexed citations
14.
15.
Chu, Joseph W.K., Frances J. Sharom, J.G. Oriol, et al.. (1997). Biochemical changes in the equine capsule following prostaglandin-induced pregnancy failure. Molecular Reproduction and Development. 46(3). 286–295. 21 indexed citations
16.
17.
Chu, Joseph W.K., Frances J. Sharom, J.G. Oriol, et al.. (1997). Biochemical changes in the equine capsule following prostaglandin‐induced pregnancy failure. Molecular Reproduction and Development. 46(3). 286–295.
18.
Buhi, W.C., I. M. Alvarez, Inho Choi, Brian Cleaver, & Frank A. Simmen. (1996). Molecular Cloning and Characterization of an Estrogen-Dependent Porcine Oviductal Secretory Glycoprotein1. Biology of Reproduction. 55(6). 1305–1314. 64 indexed citations
19.
Cleaver, Brian & Dan C. Sharp. (1995). Luteinizing Hormone Secretion in Anestrous Mares Exposed to Artificially Lengthened Photoperiod and Treated with Estradiol1. Biology of Reproduction. 52(monograph_series1). 449–457. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunichi Suzuki Breakdown of academic impact, for papers by Hironori Okada Breakdown of academic impact, for papers by Peter L Whitfeld Breakdown of academic impact, for papers by Ilona Zvetkova Breakdown of academic impact, for papers by Lisa Clepper Breakdown of academic impact, for papers by Pádraig Hart Breakdown of academic impact, for papers by Peter S. Mountford Breakdown of academic impact, for papers by Oskar Lechner Breakdown of academic impact, for papers by J. Teyssier Breakdown of academic impact, for papers by Maria Strazzullo
Rankless by CCL
2026